Search / Trial NCT06612996

Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

Launched by AL-AZHAR UNIVERSITY · Sep 23, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Tramadol Magnesium Sulphate Shivering

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - American Society of Anesthesiologists (ASA) I and II physical status undergoing an elective surgery under spinal anesthesia.
  • Exclusion Criteria:
  • * history of uncontrolled comorbidities, cardiac, respiratory, renal or hepatic disease, patients who had allergy to any medication in the study, contraindications to spinal anesthesia (coagulation disorder, infection at site of puncture, raised intracranial tension or any spine deformity), fever \>38 Celsius or less than 36 Celsius, body mass index more than 35 and who has history of alcohol intake

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0